Exonics Therapeutics
Geography
United States of America based
United States of America based
Funding
$45 M
$45 M
Exonics Therapeutics is developing transformative SingleCut CRISPR gene repair therapies for devastating genetic neuromuscular diseases
Technologies
CRISPR StartupsPosts Mentioning This Company
R&D Platform
Pipelines
No pipelines published yet
Products
Services
No services posted yet
